Clinical research on treatment of advanced androgen independent prostate cancer with Docetaxel and Thalidomide
β Scribed by Jing Tian; Donghai Teng; Xiangdong Shu; Hong Lu; Hui Chen; Peng Guo
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 73 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1610-1979
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The current study evaluated the analgesic activity and impact on quality of life (QOL) of a new chemotherapy regimen of calcitriol and docetaxel in men with androgenβindependent prostate carcinoma. ## METHODS Analgesic response was defined as a 2βpoint reduction on the
## Abstract ## BACKGROUND. The addition of diethylstilbestrol to docetaxel modified tubulin composition and improved the response of prostate cancer to chemotherapy in preclinical models. An attempt was made to recapitulate the observations in a clinical trial. ## METHODS. Twentyβnine patients w